Day: January 10, 2023
AURORA, Ontario, Jan. 10, 2023 (GLOBE NEWSWIRE) — Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q4 & YEAR END 2022 RESULTS and 2023 OUTLOOK CONFERENCE CALL
FRIDAY – FEBRUARY 10, 2023 8:00 AM ET
DIAL IN NUMBERSToll-Free:
1-800-891-9945International:
1-416-981-9017Webcast:
www.magna.comSlide presentation will be available on our website prior to the call
REBROADCAST INFORMATIONReplay available 2 hours after the call until February 17, 2023Toll-Free:
1-800-558-5253International:
1-416-626-4100Reservation No.:
22025718INVESTOR CONTACTLouis Tonelli, Vice-President, Investor Relations louis.tonelli@magna.com 905-726-7035
TELECONFERENCE CONTACTNancy Hansford, Executive Assistant, Investor Relations nancy.hansford@magna.com 905-726-7108
Occidental to Announce Fourth Quarter Results Monday, February 27, 2023; Hold Conference Call Tuesday, February 28, 2023
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Jan. 10, 2023 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) will announce its fourth quarter 2022 financial results after close of market on Monday, February 27, 2023, and will hold a conference call to discuss results on Tuesday, February 28, 2023, at 1 p.m. Eastern/12 p.m. Central.
The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10173524/f531c7c588.
Fourth quarter 2022 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed.
About Occidental
Occidental is an international energy company...
Optimi Health Announces Re-Appointments to Board of Directors
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik, Mr. Jacob Safarik, Mr. Jon Schintler, Mr. Dane Stevens, and Mr. JJ Wilson have been re-elected to the Board of Directors following the Company’s Annual General Meeting held January 9, 2023. The Company would like to thank departing director Mr. Michael Stier for his service and wishes him well in his future endeavours. Optimi shareholders also re-appointed Smythe LLP as auditor and re-approved the Company’s Equity Incentive Plan.
ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)
Optimi Health Corp. is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and synthetic psychedelic substances,...
Presentation of Preclinical Study Highlighting Anti-Cancer Activity of Rencofilstat in Combination with Proteosome Inhibitors
Written by Customer Service on . Posted in Public Companies.
EDISON, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced that its research collaborator, Carlos Perez-Stable, PhD, from the University of Miami Miller School of Medicine and Miami Veterans Affairs/Research, today presented new findings from a preclinical study on the Company’s lead drug candidate, rencofilstat, a potent inhibitor of cyclophilins, in a presentation at the 2023 State of Florida Cancer Symposium in Tampa, Florida.
The presentation, entitled “A New Strategy to Increase Proteotoxic Stress in Prostate Cancer,” highlighted a preclinical...
Dime Community Bancshares to Release Earnings on January 27, 2023
Written by Customer Service on . Posted in Public Companies.
HAUPPAUGE, N.Y., Jan. 10, 2023 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company”) today announced that the Company expects to release its earnings for the quarter ended December 31, 2022 before the open of the U.S. equity markets on Friday, January 27, 2023. The Company will conduct a conference call at 8:30 a.m. (ET) on Friday, January 27, 2023, during which Chief Executive Officer (“CEO”), Kevin O’Connor, will discuss the Company’s fourth quarter financial performance. There will be a question-and-answer period after the CEO remarks. The conference call will be simultaneously webcast (listen only) and archived for a period of one year at https://events.q4inc.com/attendee/499210648.Conference Call Details: Dial-in for Live Call:
United States:
1-844-200-6205International:
+1-929-526-1599Access...
Palomar Holdings, Inc. Announces New Fronting Partnership with Advanced AgProtection
Written by Customer Service on . Posted in Public Companies.
~ Palomar Specialty Insurance Company Authorized as the Fourteenth Approved Insurance Provider in the United States by the Federal Crop Insurance Corporation (“FCIC”) ~
~ Expands PLMR-FRONT into the ~$20 billion United States Crop Insurance Market ~
LA JOLLA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced it has entered into a new multi-year fronting arrangement with Advanced AgProtection, a managing general agent (“MGA”).
Advanced AgProtection is a leader in the crop insurance sector based upon their advanced technology and proprietary decisioning tools specific to the United States farming community. Advanced AgProtection provides crop insurance products using their deep expertise and innovative technology and analytics which are designed to manage standard...
K92 Mining Announces Record Annual Production, Achieves Guidance, Record Ore Mined, Ore Processed and Development
Written by Customer Service on . Posted in Public Companies.
Figure 1
Quarterly Total Ore Processed, Development Metres Advanced and Total Mined Material ChartStrong quarterly production, the second highest on record, of 35,538 oz of gold equivalent (“AuEq”)(1) or 31,204 oz gold, 1,827,085 lbs copper and 40,517 oz silver and quarterly sales of 35,212 oz gold, 1,923,116 lbs copper and 44,828 oz silver.Record annual production, increasing 18% year over year, of 122,806 oz AuEq or 107,546 oz gold, 6,247,950 lbs copper and 126,043 oz silver, achieving the guidance range of 115,000 to 140,000 oz AuEq.Record quarterly ore processed of 121,686 tonnes or 1,323 tpd (“tonnes per day”), a 22% increase from Q4 2021. Head grade during the quarter of 8.75 g/t gold, 0.74% copper and 13.31 g/t silver (9.98 g/t AuEq) with metallurgical recoveries for gold of 91.2% and copper of 91.8%.Record daily mill...
Cipher Mining Announces December 2022 Operational Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Odessa
Odessa Data Center Area COdessa
Odessa Data Center Staging AreaProduces 225 Bitcoin and Achieves New All-Time High Hash Rate Capacity of 2.8 EH/s in December 2022
NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”), a leading developer and operator of bitcoin mining data centers, today announced unaudited production and operations updates for December 2022.
Key HighlightsKey Metrics
December 2022*BTC Mined
225BTC Sold
39BTC Held
394Deployed Fleet
28,000Month End Operating Hash Rate (EH/s)
2.8*Approximate values
Management Commentary In December, in addition to operating its first three data centers, Cipher continued its buildout at Odessa at maximum velocity. Cipher started the month with the potential to mine up to ~3.6 bitcoin in a day at Odessa...
Saratoga Investment Corp. Announces Fiscal Third Quarter 2023 Financial Results
Written by Customer Service on . Posted in Dividend Reports And Estimates.
NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its 2023 fiscal third quarter, with Net Investment Income (“NII”) per share notably up 30% over the prior quarter and up 84% over the year ago quarter, and Adjusted NII per share up 33% and 45%, respectively, over those same periods. This increase in earnings reflects the positive effects of rising rates on the Company’s asset and credit structure, comprised of income from its largely floating rate assets in contrast to expenses from its largely fixed rate credit liabilities.
Summary Financial Information
The Company’s summarized financial information is as follows:
For the threemonths ended andas of November 30,2022
For the...
Eagle Pharmaceuticals Provides Business Update and Guidance for 2023
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
WOODCLIFF LAKE, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided a business update and guidance for 2023.
Highlights:During the 12 months ended September 30, 2022, Eagle recorded net income of $21.3 million or $1.63 per diluted share and adjusted EBITDA of $125.6 million and non-GAAP earnings per diluted share of $7.54, a significant increase from 2021.1
Eagle exited 2022 with an approximate 6%2 share of the commercial segment of the pemetrexed market for its PEMFEXY® product, equating to approximately $8 million per quarter in revenue3, and anticipates doubling its share by the end of Q1 2023. The Company bought down future royalties on PEMFEXY profits in exchange for a one-time payment of $15 million.4
Expects U.S. bendamustine franchise decline to be...